`Date Filed: February _, 2017
`
`Filed On Behalf Of:
`
`Alkermes Pharma Ireland Limited and
`Alkermes Controlled Therapeutics, Inc.
`
`By:
`
`Scott K. Reed
`
`sreed@fchs.com
`212-218-2100
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`LUYE PHARMA GROUP LTD., LUYE PHARMA (USA) LTD., SHANDONG
`LUYE PHARMACEUTICAL C0,, LTD., and NANJING LUYE
`PHARMACEUTICAL CO., LTD.,
`Petitioners,
`V.
`
`ALKERMES PHARMA IRELAND LTD and ALKERMES CONTROLLED
`THERAPEUTICS, INC.
`Patent Owners.
`
`Case IPR2016—01096
`
`U.S. Patent No. 6,667,061
`
`PATENT OWNERS’ POWER OF ATTORNEY
`
`
`
`Further to the Patent Powers’ Power of Attorney submitted on June
`
`20, 2016 as Paper 8, Patent Owners Alkermes Pharma Ireland Ltd. and Alkermes
`
`Controlled Therapeutics Inc. hereby appoint Ha Kung Wong (pro hac vice
`
`pending), Christina Schwarz (pro hac vice pending), Melinda Roberts (pro hac
`
`vice pending), and Una Fan (pro hac vice pending) as additional back-up counsel
`
`to prosecute the aforementioned proceeding and to transact all business in the
`
`United Patent and Trademark Office connected therewith.
`
`Please continue to address all correspondence as follows:
`
`Scott K. Reed
`
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104-3800
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`sreed@fchs.com
`
`Dated:
`
`,2017 Dated:
`
`[Ti
`
`ljélac/cLa,g ,20l7
`
`Shane Cooke
`President
`Alkermes Pharma Ireland Ltd.
`Connaught House
`I Burlington Road
`Dublin 4, Ireland D04 C5Y6
`
`0
`Claire M. Vasios, P]h.D.
`Vice President, Intellectual Property
`Alkermes Controlled Therapeutics, Inc.
`852 Winter Street
`Waltham, MA 0245]
`
`
`
`Paper No. _
`Date Filed: February _, 2017
`
`Filed On Behalf Of:
`
`Alkermes Pharrna Ireland Limited and
`
`Alkermes Controlled Therapeutics, Inc.
`
`Scott K. Reed
`
`sreed@fchs.com
`
`212-218-2100
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`LUYE PHARMA GROUP LTD., LUYE PHARMA (USA) LTD., SHANDONG
`LUYE PHARMACEUTICAL C0,, LTD., and NANJING LUYE
`
`PHARMACEUTICAL CO., LTD.,
`
`Petitioners,
`V.
`
`ALKERMES PHARMA IRELAND LTD and ALKERMES CONTROLLED
`
`THERAPEUTICS, INC.
`
`Patent Owners.
`
`Case IPR2016-01096
`
`U.S. Patent No. 6,667,061
`
`PATENT OWNERS’ POWER OF ATTORNEY
`
`
`
`20, 2016 as Paper 8, Patent Owners Alkermes Pharma Ireland Ltd. and Alkermes
`
`Controlled Therapeutics Inc. hereby appoint Ha Kung Wong (pro hac vice
`
`pending), Christina Schwarz (pro hac vice pending), Melinda Roberts (pro hac
`
`vice pending), and Una Fan (pro hac vice pending) as additional back-up counsel
`
`to prosecute the aforementioned proceeding and to transact all business in the
`
`United Patent and Trademark Office connected therewith.
`
`Please continue to address all correspondence as follows:
`
`Scott K. Reed
`
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104-3800
`
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`sreed@fchs.corn
`
`Dated: Zo V:<.S,>.—.,.:.,,__,:
`
`, 2017 Dated:
`
`, 2017
`
`Richie Paul
`
`Claire M. Vasios, Ph.D.
`
`Director
`Alkermes Pharma Ireland Ltd.
`Connaught House
`1 Burlington Road
`Dublin 4, Ireland D04 C5Y6
`
`Vice President, Intellectual Property
`Alkermes Controlled Therapeutics, Inc.
`852 Winter Street
`Waltham, MA 02451
`
`FCHS_WS 13 l96549v 1 .doc
`
`